Filing Flows › Comparisons › OPK vs SDGR
Opko Health vs Schrodinger: OPK and SDGR compared
Opko Health is the larger company: $65.4M of revenue in its latest quarter (Q3 2026) against $64.5M for Schrodinger (Q3 2026). Schrodinger is growing faster (+19% against +16% a year earlier). Schrodinger is more profitable, with an operating margin of -40.5% against -48.0%.
Where the money goes: OPK and SDGR
Opko Health (OPK) · Q3 2026
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
Schrodinger (SDGR) · Q3 2026
Schrodinger, Q3 2026: revenue $64.5M (+19% year over year), operating margin -40.5%, net loss $37.7M, operating cash flow −$47.6M. The chart follows the revenue to costs, profit and cash.
| Opko Health (OPK) | Schrodinger (SDGR) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $65.4M | $64.5M |
| Revenue growth, Y/Y | +16% | +19% |
| Operating margin | -48.0% | -40.5% |
| Net earnings | −$53.5M | −$37.7M |
| Net margin | -81.8% | -58.5% |
| Operating cash flow | −$36.3M | −$47.6M |
| Market value | — | $2.0B |
| Analysts’ mean target | — | $29.57 |
Where the revenue comes from
Opko Health
- Product: $41.8M (64%)
- License and Service: $23.6M (36%)
Schrodinger
- Software products and services: $38.2M (59%)
- Drug discovery: $24.2M (38%)
- Contribution: $2.2M (3%)
Questions
Which is bigger, Opko Health or Schrodinger?
Opko Health is the larger company: $65.4M of revenue in its latest quarter (Q3 2026) against $64.5M for Schrodinger (Q3 2026).
Is Opko Health or Schrodinger growing faster?
Schrodinger is growing faster (+19% against +16% a year earlier).
Which is more profitable, Opko Health or Schrodinger?
Schrodinger is more profitable, with an operating margin of -40.5% against -48.0%.
More: Opko Health earnings · how Opko Health makes money · Schrodinger earnings · how Schrodinger makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.